Mercia in £5m series-A for Aston EyeTech

The firm secured a 19.4% stake in Aston via the transaction, which will fund product development and the launch of the company's latest products.

An Asia-based investment syndicate also took part in the funding round.

Mercia has worked alongside Aston EyeCare for three years, according to a statement, having previously invested in the startup via its managed funds portfolio at both the seed and early stages.

Company
Aston was founded in 2014 as a spinout from Aston University, Birmingham. It develops software and produces portable and digital eye tests, which combine to diagnose and manage ocular fatigue. The business is generating revenue.

People
Aston EyeTech – Carl Francis (CEO).
Mercia Technologies – Peter Dines (head of life sciences and biosciences).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Healthcare
• United Kingdom
• Venture